FOLH1 and prostate carcinoma: The antigen is a transmembrane protein that is overexpressed by prostate cancer cells up to 1000-fold compared to normal prostatic tissue.35 It is noteworthy that increasingly aggressive prostate cancers have increased expression of PSMA.36